Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic ...

Bacillus subtilis has emerged as a pre‐eminent model organism for the study and application of protein expression and secretion, owing to its robust secretory pathways and genetic tractability. Its ...

Escherichia coli remains at the forefront of recombinant protein production, owing to its rapid growth, well-characterised genetics and the ease with which it can be genetically manipulated. The ...

The cost-effective, easy-to-use T7 expression system has been integral to Escherichia coli protein production since its introduction in 1986. Now, a just-developed enhancement is making it even better ...

Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...

Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...

LX2020 generally well tolerated across ten participants with no clinically significant complement activation LX2020 transduction, transcription, ...

The current study explored how macronutrients in the host diet are involved in gut colonization and competition by V.

Aging is inevitable, but how quickly visible aging shows up—especially in the skin—is influenced by far more than birthdays ...

The first-in-human phase 1/2 study of TSN1611, a highly selective KRAS G12D inhibitor, in patients with advanced solid tumors. Seizure-related homolog 6 (SEZ6) expression and ctDNA methylation ...